ALGOMEDIX, INC.
Biotech · Private
Small molecule TRPA1 antagonist therapeutic to prevent and treat chemotherapy-induced peripheral neuropathy (CIPN)
algomedix.com →- Grants
- $1.6M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 2 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · TRPC6 Antagonists as Therapeutics for Chronic Kidney Disease | $296,818 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a TRPA1 Antagonist Opioid-Sparing Analgesic for Chronic Pain | $734,315 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Therapeutic TRPA1 Mechanism-Based Treatment of Chemotherapeutic-Induced Neuropathic Pain | $291,147 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Therapeutic TRPA Mechanism Based Treatment of Chemotherapeutic Induced Neuropathic Pain | $291,147 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2040 | Cell X Technologies, Inc. | — | — |
| 2041 | UP ONCOLYTICS, INC. | — | — |
| 2042 | JPT America, Inc. | — | $600K |
| 2043 | ALGOMEDIX, INC. | — | — |
| 2044 | Scale-Up International Inc. | — | $84K |
| 2045 | Tango Biosciences Inc. | — | — |
| 2046 | AVIARA PHARMACEUTICALS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- TRPA1 Antagonists For Treatment Of Dry Eye, Ocular Pain And Inflammationapplication
- TRPA1 Modulatorsgranted
- TRPA1 Modulatorsgranted
- TRPA1 Antagonists For Treatment Of Dry Eye, Ocular Pain And Inflammationapplication
- TRPA1 Antagonists For Treatment Of Dry Eye, Ocular Pain, And Inflammationapplication
- TRPA1 Modulatorsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.